Evaluation of fibroblast activation protein-specific PET/CT in a patient with post-COVID pneumonitis.
Khaled MusamehShane O'BrienRoshane MehboobThomas ButlerZara CunninghamCarol BuckleyArmin AtzingerTorsten KuwertPatrick MitchellSeamas C DonnellyPublished in: Respirology case reports (2024)
Coronavirus disease 2019 (COVID-19) often leads to a spectrum of pulmonary complications, including interstitial lung disease (ILD) with the potential for fibrotic sequelae. Assessing the presence of ongoing active inflammation versus established residual fibrosis as a result of lung parenchymal injury and repair in these patients is a clinical challenge. Better understanding of the disease process is crucial for guiding appropriate therapeutic strategies. We aim to investigate the use of positron emission tomography / computer tomography (PET/CT) scans and their role in diagnosing interstitial pneumonitis (IP) post COVID infections.
Keyphrases
- pet ct
- coronavirus disease
- interstitial lung disease
- positron emission tomography
- systemic sclerosis
- idiopathic pulmonary fibrosis
- computed tomography
- sars cov
- rheumatoid arthritis
- end stage renal disease
- respiratory syndrome coronavirus
- newly diagnosed
- ejection fraction
- chronic kidney disease
- oxidative stress
- pulmonary hypertension
- prognostic factors
- pet imaging
- deep learning
- case report
- peritoneal dialysis
- magnetic resonance
- risk assessment
- magnetic resonance imaging
- risk factors
- wound healing
- liver fibrosis
- patient reported
- dual energy